PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma

Clinical trial NCT02991482 · COMPLETED

Trial details

NCT number: NCT02991482
Sponsor: ETOP IBCSG Partners Foundation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pleural Mesothelioma Malignant Advanced

Start date: 2017-09-12
Primary completion: 2019-02-20
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.